# Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers

> **NCT02182154** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BIBF 1120 ES

## Key facts

- **NCT ID:** NCT02182154
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2005-11
- **Final completion:** —
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182154, "Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02182154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*